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Genome-Wide Mutant Fitness Profiling Identifies Nutritional
Requirements for Optimal Growth of Yersinia pestis in Deep Tissue
Samantha G. Palace,a Megan K. Proulx,a Shan Lu,b Richard E. Baker,a Jon D. Goguena
Department of Microbiology and Physiological Systemsa and Laboratory of Nucleic Acid Vaccines, Department of Medicine,b University of Massachusetts Medical School,
Worcester, Massachusetts, USA
ABSTRACT Rapid growth in deep tissue is essential to the high virulence of Yersinia pestis, causative agent of plague. To better
understand the mechanisms underlying this unusual ability, we used transposonmutagenesis and high-throughput sequencing
(Tn-seq) to systematically probe the Y. pestis genome for elements contributing to fitness during infection. More than a million
independent insertion mutants representing nearly 200,000 unique genotypes were generated in fully virulent Y. pestis. Each
mutant in the library was assayed for its ability to proliferate in vitro on rich medium and in mice following intravenous injec-
tion. Virtually all genes previously established to contribute to virulence following intravenous infection showed significant fit-
ness defects, with the exception of genes for yersiniabactin biosynthesis, which were masked by strong intercellular complemen-
tation effects. We also identified more than 30 genes with roles in nutrient acquisition andmetabolism as experiencing strong
selection during infection. Many of these genes had not previously been implicated in Y. pestis virulence. We further examined
the fitness defects of strains carrying mutations in two such genes—encoding a branched-chain amino acid importer (brnQ) and
a glucose importer (ptsG)—both in vivo and in a novel defined synthetic growth medium with nutrient concentrations matching
those in serum. Our findings suggest that diverse nutrient limitations in deep tissue play a more important role in controlling
bacterial infection than has heretofore been appreciated. Because much is known about Y. pestis pathogenesis, this study also
serves as a test case that assesses the ability of Tn-seq to detect virulence genes.
IMPORTANCE Our understanding of the functions required by bacteria to grow in deep tissues is limited, in part because most
growth studies of pathogenic bacteria are conducted on laboratory media that do not reflect conditions prevailing in infected
animal tissues. Improving our knowledge of this aspect of bacterial biology is important as a potential pathway to the develop-
ment of novel therapeutics. Yersinia pestis, the plague bacterium, is highly virulent due to its rapid dissemination and growth in
deep tissues, making it a goodmodel for discovering bacterial adaptations that promote rapid growth during infection. Using
Tn-seq, a genome-wide fitness profiling technique, we identified several functions required for fitness of Y. pestis in vivo that
were not previously known to be important. Most of these functions are needed to acquire or synthesize nutrients. Interference
with these critical nutrient acquisition pathways may be an effective strategy for designing novel antibiotics and vaccines.
Received 23 May 2014 Accepted 16 July 2014 Published 19 August 2014
Citation Palace SG, Proulx MK, Lu S, Baker RE, Goguen JD. 2014. Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis
in deep tissue. mBio 5(4):e01385-14. doi:10.1128/mBio.01385-14.
Editor Eric Rubin, Harvard School of Public Health
Copyright © 2014 Palace et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported
license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Jon D. Goguen, jon.goguen@umassmed.edu.
Serendipitous quirks of Yersinia biology catalyzed much of theresearch into the molecular basis of Y. pestis pathogenesis in
the last three decades. For example, the finding that the addition of
skimmilk to the growthmedium enhanced retention of virulence
of Y. pestis cultured at 37°C (1) ultimately led to the discovery of
type III secretion (2). The identification of the yersiniabactin sid-
erophore system required for bacterial iron acquisition during
infection (3, 4) was similarly prefaced by the observation that the
ability of Y. pestis to form pigmented colonies on medium con-
taining hemin was somehow linked to virulence (5, 6). A large
fraction of current research on Yersinia virulence centers exclu-
sively on the few virulence determinants discovered by these early
efforts. To date, these studies have largely eclipsed more system-
atic attempts to define virulence determinants and other impor-
tant factors contributing to severity of disease.
The limitations of previous iterations of whole-genome tech-
niques are partly responsible for this focus. Prior genome-level
studies of Y. pestis relied on acquisition of gene expression data
under various in vitro and in vivo conditions (7–11). These results
provide a deeper understanding of physiological adaptations em-
ployed by the bacterium in different environments; however, gene
expression data have not proved to be a reliable predictor of viru-
lence determinants (12–14). Attempts to circumvent this problem
by directly measuring the functional contribution of Y. pestis
genes to bacterial growth in vivo have been more successful but
rely on measuring the fitness of a defined panel of mutants rather
than implementing a truly unbiased genome-scale technique (15).
Recently, the combination of transposon mutagenesis and
high-throughput sequencing has provided amore direct approach
to functional genomics. This method has been assigned several
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names, includingHITS (16), TraDIS (17), INSeq (18), and Tn-seq
(19). Tn-seq employs deep sequencing to map and count trans-
poson/genome junctions from a dense library of random trans-
poson insertion mutants grown en masse under each condition of
interest. The number of transposon insertions detected in a given
gene reflects the prevalence of the corresponding mutants in the
library following selection (20). This information can be used to
estimate relative fitness for mutants in different growth environ-
ments.
Tn-seq is an increasingly popular tool in studies of bacterial
pathogens (14, 16–31), although to date only five pathogens have
been examinedusing animal infection as a selection regime (Strep-
tococcus pneumoniae [23, 26], Haemophilus influenzae [16], Yer-
sinia pseudotuberculosis [25], uropathogenic Escherichia coli [30],
and Mycobacterium tuberculosis [31]). Here, we used Tn-seq to
measure the fitness of nearly 200,000 unique Y. pestis insertion
mutants during growth in vitro in rich culture medium and in
mice following intravenous inoculation. We identified several
genes contributing to bacterial fitness during infection that had
not previously been implicated in virulence, including more than
30 genes with roles in nutrient import and metabolism. The ma-
jority of known virulence factors required for optimal bacterial
growth during infection were also required in the Tn-seq data set,
underscoring the suitability of thismethod in the context of infec-
tion studies.
RESULTS
Transposon mapping of the Yersinia pestis genome. We mu-
tagenized the fully virulentY. pestis strainKIM1001 (see Text S1 in
the supplemental material) with a himar1-derived transposon to
construct a bank of approximately 1.5 million independent inser-
tion mutants. To select against mutants harboring insertions in
genes required for growth in vitro, the insertion library was grown
on TB, a complex medium adapted from tryptose blood agar base
that provides a broadly permissive growth condition for insertion
mutants.
To select against mutants harboring insertions in genes re-
quired for growth during mammalian infection, we performed
intravenous infections of three C57BL/6mice with 2.3 107 CFU
of the insertion library, which resulted in a population of ~106
bacteria in each spleen 1 h postinfection. This infection route pre-
serves library diversity by circumventing bottlenecks imposed by
peripheral routes of infection. Bacteria were recovered from
spleens 40 h postinfection by plating on TB agar. Bacterial popu-
lations in the spleen at the time of harvest averaged 1.63 
109 CFU/spleen (ranging from 1.4 109 to 2.1 109). This pop-
ulation expansion is in excess of 1,000-fold, large enough to per-
mit detection of modest reductions in fitness even in the absence
of bacterial killing by host defenses.
Following selection, we mapped the transposon insertions
present in the bacterial populations recovered from the in vitro
and in vivo expansions via selective amplification of transposon-
genome junctions and Illumina sequencing, using methods simi-
lar to those previously described (see Text S1 in the supplemental
material). The himar1 transposon derivative used formutagenesis
inserts at TA dinucleotides (32, 33). Approximately 69% (187,780
of 271,354) of TAs in the Y. pestis KIM genome harbored inser-
FIG 1 Dense transposon mapping of the Y. pestis genome allows identification of regions under selection. The number of insertions sequenced at each site is
represented by bar height (log scale). Circular plots were generated using the software program CGView (62). (A) Transposon insertions mapping to the
chromosome. Large gaps correspond to blocks of essential genes, such as the NADH dehydrogenase subunits (inset; insertions are shown by the Integrated
Genomics Viewer software tool [63, 64] on a log scale). (B) Transposon insertions mapping to the type III secretion plasmid pCD1. Insertions in many genes in
the first 30 kb of pCD1, which encode regulatory and structural components of the type III secretion system, are selected against in vivo (outer ring; red bars) but
not in vitro (inner ring; blue bars). The gap of insertions at the 60-kb mark corresponds to plasmid replication genes.
Palace et al.
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tions, an average density of 39 insertions per kilobase. This high
density of insertions allowed fine-scale mapping of functional ge-
netic units, including intergenic regions (Fig. 1A). The density of
mutations on pMT1, pCD1, and pPCP1, the three plasmids pres-
ent in Yersinia pestis KIM, was similar to that on the chromosome
(78%onpMT1, 76%onpPCP1, and 63%onpPCP1, compared to
69% on the chromosome) (Fig. 1B). Although substantial large-
scale heterogeneity in insertion density has been observed after
similar transposon mutagenesis of other pathogens (21, 34), in-
sertions in our library were distributed relatively evenly across the
chromosome (Fig. 1A).
Identifying genes required for optimal growth in vitro. To
identify genes required for optimal growth of Y. pestis on rich
medium, we analyzed the full set of Y. pestis KIM open reading
frames (ORFs) annotated in the NCBI database by two distinct
mathematical approaches formeasuring the effect of insertions on
fitness.
In the first approach, we estimated the relative fitness (W) of
mutants harboring insertions in each chromosomal ORF, using
an analysis similar to that described by van Opijnen and Camilli
(35). In the context of evolutionary biology, relative fitness is de-
fined as the ratio of the rates of population expansion for the two
genotypes being compared.Mutants with relative fitness of1 are
defective in growth or survival relative to the wild type, while
mutants with relative fitness of1 are more fit than the wild type.
To test the statistical significance of the observed changes in fitness
for each gene, we employed a nonparametric approach based on a
reference distribution created by resampling insertion frequencies
in TA sites in nonessential ORFs (defined as those with relative
fitness between 0.95 and 1.05) and plotted relative fitness versus
FIG 2 Selection of chromosomal Y. pestis genes during growth in vitro on rich medium. (A) The relative fitness of mutants in each chromosomal ORF plotted
against significance (calculated by resampling; see Text S1 in the supplementalmaterial). Genes harboring no sequenced insertions in the central 90%of theORF
(relative fitness 0) are shown in the box at the left of the plot. (B) Relative fitness (histogram) correlates well to essentiality, as predicted by the hiddenMarkov
model recently published by DeJesus and Ioerger (36) (red, essential; yellow, growth-deficient; green, nonessential). Genes harboring no sequenced insertions in
the central 90% of the ORF (relative fitness 0) are shown at the left of the plot. (C) Three examples of genes withmodest reductions in relative fitness that were
predicted to be essential by the hiddenMarkovmodel. Many genes in this class contain groups of consecutive TA sites that do not harbor insertions (red boxes),
suggesting domain architecture. For example, the apparently essential N terminus of the rne gene is highly homologous to the essential E. coli gene of the same
name (65, 66), while the evidently nonessential C terminus is highly divergent from the E. coli homologue, as has been reported for several other species (67); also
shown is the apparently essential C-terminal DNA-binding domain of the rcsB gene, a transcriptional activator with multiple roles, including small RNA
production and cell division (68). Insertions are shown by the Integrated Genomics Viewer software tool (63, 64) on a log scale.
Optimal Growth of Yersinia pestis in Deep Tissue
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significance (Fig. 2A) (for method details, see Text S1 in the sup-
plemental material; for complete results, see Table S1).
A drawback of this first approach is its insensitivity to ORFs
containing multiple functional domains with differing contribu-
tions to fitness. To address this problem, we used the hidden
Markov model (HMM) recently developed by DeJesus and Io-
erger (36). This method classifies genes as essential, growth disad-
vantaged, nonessential, or growth advantaged. A complete list of
classification of ORFs by the HMM algorithm is available in Ta-
ble S2 in the supplemental material, and the metabolic pathways
most commonly represented by this list of genes, asmapped by the
Kyoto Encyclopedia of Genes andGenomes (37), are summarized
in Table S3. Relative fitness values were good predictors of HMM
class (Fig. 2B), indicating general agreement of these two meth-
ods. However, a small number of genes classified as essential or
growth deficient by the HMM were assigned relatively high rela-
tive fitness values (above 0.75).
In some cases, these results are consistent with known domain
structure; this algorithm is particularly sensitive to consecutive TA
sites without insertions and therefore correctly classifies ORFs
containing subgenic essential domains (Fig. 2C). However, other
genes in this group have insertion patterns that render their clas-
sification suspect (discussed fully in Text S2 in the supplemental
material). These include genes with relatively short (20) runs of
insertion-free TAs, which are less likely to represent functional
protein domains, and runs of insertion-free TAs in unusually AT-
rich sequences, which may be more difficult to sequence due to
base composition bias in library preparation and/or Illumina se-
quencing (38).
The HMM analysis also identifies some plasmid genes as es-
sential, including genes required for plasmid replication. The
apparent selection on these genes does not stem from any essential
function of the plasmids but instead reflects the biological impos-
sibility of propagating insertions that prevent the replication of
their host genetic element. The plasmid pCD1, which encodes the
Y. pestis type III secretion system (T3SS), harbors a second class of
genes that the HMM scores as essential or growth deficient. The
majority of these are involved in regulating type III secretion
(T3S) activity (e.g., yscM, lcrGVH, and lcrD), and insertions in
these genes are underrepresented because uncontrolled expres-
sion of the T3SS at 37°C in vitro inhibits growth of Y. pestis (e.g.,
see reference 39). Curiously, the pattern of T3SS genes selected
in vitro deviates somewhat from currentmodels of T3S regulation.
In particular, the regulatory gene lcrE (sometimes called yopN)
was not subject to significant selection under our in vitro condi-
tion (falling into the nonessential HMM class), and we observed
unexpectedly strong selection against yopB mutants in vitro. We
do not conceive a simple explanation for these unexpected phe-
notypes and suggest that this regulatory scheme may require fur-
ther investigation.
Identifying genes selected during infection. Because we were
particularly interested in identifying genes required for optimal
growth and survival during infection, we calculated the relative
fitness of insertion mutants from the in vivo Tn-seq data set. To
determine whether the period of growth in vivo significantly
changed the abundance of insertion mutants for each gene, we
developed a nonparametric statistic based on a reference distribu-
tion created by permuting insertion frequencies in the relevant
ORF from both the in vitro and in vivo data sets (see Text S1 in the
supplemental material) and plotted the relative fitness versus sig-
nificance (Fig. 3A). A complete table of these values is provided in
Table S1. Rare genes with substantial reductions in in vivo relative
FIG 3 Comparison of Tn-seq data sets to find chromosomal genes required during mammalian infection. (A) Volcano plot for identification of chromosomal
genes selected in vivo. Each gene was compared between two in vitro data sets (filled pale blue squares) or between an in vitro data set and the in vivo data set (gray
circles). Genes experiencing significant selection in vivo are represented by black circles. For each gene, relative fitness of insertion mutants in vivo is given with
respect to the fitness of a wild-type strain. Significance is calculated by permuting the number of insertions sequenced at each TA in the gene between the two data
sets (see Text S1 in the supplemental material). Genes selected in vivo appear in the upper-left quadrant, while any genes that harbormore insertions in vivo than
in vitro should track to the upper-right quadrant. Genes harboring no sequenced insertions in vivo in the central 90% of the ORF (relative fitness 0) are shown
in the box at the left of the plot. (B) Genes experiencing strong selection (psn and brnQ) harbor many fewer insertions after growth in vivo. The same effect is
present but less pronounced in genes experiencing moderate levels of selection (ptsG). Insertions are shown by the Integrated Genome Viewer tool (63, 64) on
a log scale.
Palace et al.
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fitness that do not reach significance (Fig. 3A, lower left of plot)
are associated with large growth defects both in vitro and in vivo
(see Text S1).
ThePCRamplification and Illumina sequencing steps required
for Tn-seq introduce variability into the measured relative abun-
dance of eachmutant in the library, leading to differences in mea-
sured abundances between libraries thatmay reflect either biolog-
ically meaningful differences or noise introduced during sample
processing. To address this problem, we independently prepared,
sequenced, and analyzed a second sample of the inoculum library
(see Table S1 in the supplemental material). The comparison of
these two technical replicates allowed us to directly observe the
extent of artifactual variation introduced by sample processing
(Fig. 3A). ORFs in the in vivo data set that met a strict P value
cutoff of 0.05 and that fell entirely outside the range of variability
observed between inoculum library replicates were considered
candidates for significantly selected genes
Fifty-three chromosomal genes met these criteria for signifi-
TABLE 1 Chromosomal Y. pestis genes experiencing significant selection in deep tissue
Gene name Gene function Relative fitness in vivo P value
arcB (y0126) Aerobic respiration control 0.798 2.00E04
y0160 Unknown function 0.681 2.90E03
pyrB (y0161) Pyrimidine biosynthesis 0.566 2.20E03
purD (y0501) Purine biosynthesis 0.345 4.00E04
purH (y0502) Purine biosynthesis 0.316 1.00E05
miaA (y0629) IPP transferase to tRNA 0 2.80E03
hflK (y0633) FtsH protease regulator 0.738 1.00E05
y0661 Conserved domain of unknown function 0.647 1.00E04
pcm (y0832) Protein L-isoaspartate O-methyltransferase 0.677 2.60E03
brnQ (y0981) Branched-chain amino acid import 0 1.00E05
purK (y1102) Purine biosynthesis 0.298 1.00E05
purE (y1103) Purine biosynthesis 0.261 6.00E04
purL (y1309) Purine biosynthesis 0.168 1.00E05
guaB (y1362) Purine metabolism 0 6.00E04
guaA (y1363) Purine metabolism 0 4.20E03
purN (y1406) Purine biosynthesis 0.534 1.70E03
purM (y1407) Purine biosynthesis 0 1.50E03
y1412 Putative zinc-dependent peptidase 0.758 1.00E05
purC (y1421) Purine biosynthesis 0 1.00E03
y1483 Putative histidine kinase sensor 0.661 1.00E05
purF (y1605) Purine biosynthesis 0.496 1.00E05
ptsG (y1767) Glucose importer 0.693 1.00E05
ndh (y1777) NADH dehydrogenase 0.589 1.00E05
y1920 LPS modification (arnD homologue) 0.317 4.00E04
y1940 Contains putative L,D-transpeptidase domain 0.548 4.10E03
tonB (y2037) Membrane transport 0 1.12E02
pyrF (y2069) Pyrimidine biosynthesis 0 2.00E02
ybtP (y2397) Siderophore import 0 3.78E02
ybtA (y2398) Regulator of siderophore biosynthesis/import 0 1.00E05
psn (y2404) Siderophore import 0.160 1.00E05
cycA (y2447) D-Alanine/D-serine/glycine permease 0.709 3.50E03
pabB (y2535) para-aminobenzoate synthesis 0.690 1.00E04
aroP (y2564) Aromatic amino acid import 0.777 1.00E05
hisF (y2627) Histidine biosynthesis 0.570 6.00E04
y2739 Putative ATP-dependent protease 0.591 7.00E04
aspC (y2760) Amino acid metabolism/biosynthesis 0.706 1.00E04
aroA (y2783) Aromatic amino acid biosynthesis 0 2.00E03
cydD (y2803) Cysteine/glutathione transport 0.799 2.00E04
cydC (y2805) Cysteine/glutathione transport 0.815 5.00E04
nrdA (y2974) Nucleotide biosynthesis 0.713 1.00E05
nrdB (y2975) Nucleotide biosynthesis 0 1.00E05
metN (y3104) Methionine transport 0 1.00E05
y3105 Methionine transport 0 1.00E05
metQ (y3106) Methionine transport 0 1.00E05
tbpA (y3651) Thiamine transport 0.545 1.00E05
thiP (y3652) Thiamine transport 0.742 1.00E05
thiQ (y3653) Thiamine transport 0 7.20E03
nhaA (y3704) Na/H antiporter 0.375 1.00E05
y3803 GTP-binding factor 0.741 4.00E04
hemN (y3807) Porphyrin metabolism 0.579 1.00E05
envZ (y3917) Histidine kinase osmosensor 0.741 1.60E03
pabA (y3953) para-aminobenzoate synthesis 0.468 1.60E03
aroE (y4028) Aromatic amino acid biosynthesis 0 8.80E03
Optimal Growth of Yersinia pestis in Deep Tissue
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cant selection in vivo (Table 1), many of which fell into common
KEGG pathways (see Table S3 in the supplemental material).
These pathways include purine and pyrimidine biosynthesis, me-
tabolism of both aromatic and certain nonaromatic amino acids,
biosynthesis of secondary metabolites, and the ABC transporter
category. Genes selected in vivo also include hypothetical genes,
genes of unknown function, and annotated genes with putative
functions that have not previously been implicated in Y. pestis
infection. Notable among these are y0661, a hypothetical gene
containing a conserved domain of unknown function, and y1920,
encoding a homologue of the lipopolysaccharide (LPS) modifica-
tion enzyme ArnD, which was recently reported to be selected in
the closely related speciesYersinia pseudotuberculosis during infec-
tion (25) (Table 1).
Branched-chain amino acid transport by BrnQ is required
for Y. pestis virulence. The putative branched-chain amino acid
importer encoded by brnQ (y0981) was among the most strongly
selected genes in vivo, despite its apparent dispensability in vitro
(Fig. 3A andB). A homologous importer has been reported to play
a role in valine uptake during intracellular growth of Chlamydia
trachomatis (40). To validate this observed in vivo fitness defect,
we constructed an in-frame deletion of brnQ in the virulent strain
KIM1001. Subcutaneous infection with 103 (Fig. 4A) or 105 (see
Fig. S1 in the supplemental material) CFU of the KIM1001brnQ
mutant failed to visibly sicken mice, while all mice infected with
wild-type KIM1001 died within 8 days. Sixty percent of mice suc-
cumbed to infection with 107 CFU of this mutant (see Fig. S1),
indicating a roughly 1-millionfold increase in mean lethal dose in
the absence of brnQ (since the 50% lethal dose [LD50] of wild-type
KIM1001 is50 CFU by subcutaneous infection [41]). Comple-
mentationwith the brnQ gene driven by its native promoter on the
low-copy-number plasmid pSP6 restored virulence (Fig. 4A).
Four days after subcutaneous infection with 1,000 CFU
KIM1001brnQ, no Y. pestis could be recovered from the homog-
enized spleens of mice (n  5; limit of detection, 101 CFU/
spleen).
To determine if infection with brnQ mutants could protect
against subsequent infection, mice surviving infection with
KIM1001brnQ (a dose of 103 CFU) were challenged 28 or
30 days after the initial infection with 103 CFU of wild-type
KIM1001. Fifteen of the sixteen mice previously infected with
KIM1001brnQ survived the challenge without visible symp-
toms, while all naive mice succumbed (Fig. 4A).
Notably, brnQ mutants were not underrepresented in the in
vitro Tn-seq data set. To investigate this phenomenon, we recon-
structed the in-frame deletion of brnQ in the attenuated strain
JG150A, allowing us to investigate growth of the mutant under
biosafety level 2 (BSL2) conditions. In accordance with the in vitro
Tn-seq data, JG150AbrnQ grew as well as the wild-type control
in the rich medium TB and had only a mild growth defect in
PMH2, a defined medium commonly used for culturing Y. pestis
(42) (Table 2; see also Fig. S2A and B in the supplemental mate-
rial). Since brnQ is annotated as an ABC transporter that imports
the branched-chain amino acids leucine, isoleucine, and valine,
we formulated a new defined medium for culturing Y. pestis to
probe for a deficiency in branched-chain amino acid acquisition.
Serum nutritional medium (SNM) contains levels of magnesium,
FIG 4 Y. pestis requires the branched-chain amino acid importer BrnQ for virulence in mice. (A) Left: subcutaneous infection with 1,000 CFU KIM1001 (w.t.)
(n  9), KIM1001brnQ (brnQ) (n  17), or the complemented strain KIM1001brnQ(pSP6) (complemented) (n  5). Mice infected with KIM1001 or
KIM1001brnQ(pSP6) diedwithin the first week of infection, while themutant KIM1001brnQ strain failed to sicken or killmice. Right: previous infectionwith
KIM1001brnQ protected 15 out of 16 mice from subcutaneous challenge with 1,000 CFU KIM1001 28- to 30 days later. (B) Growth of the attenuated strains
JG150A (w.t.), JG150AbrnQ (brnQ), and JG150AbrnQ(pSP6) (complemented) in the defined serum-like medium SNM alone (left) or supplemented with
2 mM leucine, isoleucine, and valine (right). Curves are representative of two independent experiments.
Palace et al.
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sodium, glucose, and all amino acids equivalent to those found in
serum (see Text S1).
The growth rate of JG150AbrnQ cultured in SNM is less than
one-fifth of the growth rate for wild-type JG150A in the same
medium (relative fitness, 0.171). As in infection studies, comple-
menting brnQ with a wild-type copy of the gene under its native
promoter in trans restored growth of the mutant to wild-type
levels (Fig. 4B). Growth could also be restored by supplementing
SNMwith 2 mM leucine, isoleucine, and valine—concentrations
similar to those in PMH2 (Fig. 4B and Table 2). Interestingly,
supplementing the medium with isoleucine and valine in the ab-
sence of leucine did not fully restore growth (see Fig. S2C in the
supplemental material), despite the presence of the apparently
functional alternative leucine uptake system LS in Y. pestis KIM
(livKHMGF; y0422-y0426) (43) that has been reported to be ex-
pressed in vivo (7).
Glucose import by PtsG provides a competitive advantage to
Y. pestis during infection. Recent work screening a defined panel
of Y. pestis mutants implicated the glucose importer encoded by
ptsG in bacterial fitness during infection (15). As with brnQ, the
Tn-seq data set identified ptsG as significantly selected in vivo, but
insertions in ptsG caused a much more modest reduction in rela-
tive fitness (0.693) (Table 1 and Fig. 3A and B). To assess the
contribution of ptsG to virulence, we subcutaneously infected
C57BL/6 mice with 1,000 CFU of the in-frame deletion strain
KIM1001ptsG. The course of disease with KIM1001ptsG did
not differ significantly from that with wild-type KIM1001 (Fig. 5).
We therefore considered the hypothesis that the decrease in
growth caused by inactivation of ptsG is insufficient to affect the
outcome of infection but that ptsG confers a competitive fitness
advantage to Y. pestis during growth in mammals.
We infected BALB/C and C57BL/6 mice intravenously with
104 CFU of KIM1001 and KIM1001ptsG in a 1:1 mixture.
Spleens were homogenized 2 and 42 h postinfection, and the pro-
portion of ptsGmutants in the spleenwas determined at each time
point. The relative frequency of KIM1001ptsGmutants declined
significantly over the course of the experiment (Fig. 6A). On av-
erage, the proportion of KIM1001ptsG mutants in the spleen
decreased from 0.434 at 2 h postinfection (i.e., 43.4%mutants) to
0.039 (3.9%) at 42 h postinfection. Assuming constant exponen-
tial growth rates during the infection, this change in frequency
corresponds to a relative fitness of 0.8 for KIM1001ptsG relative
to wild-type KIM1001, a value close to that determined form the
Tn-seq experiments (Table 1).
We were able to recapitulate this phenotype in vitro in the
defined serum-like medium SNM. Five replicate cultures were
inoculated with equal numbers of the attenuated (T3SS-deficient)
strains JG102 and JG102ptsG. After 42 h of continuous log-phase
growth, the proportion of ptsG mutants in the culture had de-
creased from0.5 to an average of 0.034 (Fig. 6B). This reduction in
frequency represents a relative fitness of 0.794 for the ptsGmutant
relative to the control strain, JG102, in the same medium, very
similar to the value of 0.8 observed in vivo. No growth defect was
detected in SNM when the JG102ptsG mutant was comple-
mented with a low-copy-number plasmid carrying ptsG under
control of its native promoter (see Fig. S3 and Text S1 in the
supplemental material).
Because PtsG is annotated as a glucose importer, we tested
whether glucose is required for the competitive advantage pro-
vided by ptsG. No fitness defect was detected for the ptsG mutant
grown in the absence of glucose (Fig. 6B), consistent with the
apparently neutral phenotype of ptsG insertion mutants in the
in vitro Tn-seq data set (Fig. 3B). In contrast, the proportion of
ptsGmutants in cultures containing glucose decreased on average
from 0.592 to 0.266 (Fig. 6B). This decrease corresponds to a rel-
ative fitness of 0.92 for JG102ptsG relative to wild-type JG102 in
this rich culture medium, supporting the hypothesis that ptsG
provides a competitive advantage to Y. pestis during infection by
permitting or increasing glucose import.
Intercellular complementation in vivo: genes required for
siderophore-mediated iron acquisition.Growth in vivo strongly
selected against insertions in the psn gene (y2404), which encodes
the outer membrane TonB-dependent yersiniabactin importer
(44), and in ybtA (y2398), the regulator required for expression of
psn and other genes in the yersiniabactin uptake system (45) (Ta-
ble 1 and Fig. 3A and B). This agrees with an extensive body of
literature describing the requirement for yersiniabactin-mediated
iron acquisition for optimal growth under iron-limiting condi-
tions (44, 46), including in vivo (4, 6, 47).
However, the genes required for biosynthesis of the yersini-
abactin siderophore (Ybt) were not selected in vitro or in vivo (see
Table S4 in the supplemental material). This apparent contradic-
tion almost certainly results from intercellular complementation.
Extracellular yersiniabactin has been reported to complement the
growth of mutants deficient in yersiniabactin biosynthesis even in
low-iron environments (44). Because our experiments were per-
formed at a relatively high bacterial density and the vast majority
of the bacterial population remains functionally wild type with
TABLE 2 The brnQ deletion mutant grows poorly at low
concentrations of branched-chain amino acids
Growth medium
Growth ratea
Relative
fitness (W)bJG150A JG150AbrnQ
TB 0.5450	 0.023 0.5301	 0.044 0.973
SNM 0.3987	 0.075 0.0681	 0.023 0.171
SNM 2 mM Leu, Ile, Val 0.4063	 0.002 0.3253	 0.001 0.801
a Growth rates of the wild-type JG150A strain and the deletion mutant JG150AbrnQ
were calculated from cultures at mid-log phase. Means and standard errors from a
minimum of two independent experiments are shown.
b In these experiments, relative fitness was calculated by taking the ratio of the
JG150AbrnQ growth rate and the JG150A growth rate.
FIG 5 The glucose importer encoded by ptsG has little effect on Y. pestis
virulence. Subcutaneous infections with 1,000 CFU KIM1001 (w.t.) (n 10)
or KIM1001ptsG (ptsG) (n 14) were carried out. Thirteen out of fourteen
mice infected with KIM1001ptsG died, with kinetics similar to those of mice
infected with KIM1001.
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respect to siderophore production, the concentration of extracel-
lular yersiniabactin is likely high enough to provide iron to mu-
tants deficient in Ybt synthesis.
Native Y. pestis plasmids. All three of the native plasmids in
Y. pestisKIM1001 have been shown to have virulence functions in
mice. To measure the contribution of plasmid genes to bacterial
fitness during infection, we calculated the in vivo relative fitness
and significance for each annotated ORF on the plasmids as de-
scribed above for chromosomal genes.
pCD1 and genes of the type III secretion system. The type III
secretion system encoded on the 70-kb plasmid pCD1 is essential
for virulence of Y. pestis. We observed very strong reductions in
relative fitness of mutants defective for many T3S genes (see Ta-
ble S4 in the supplemental material). For example, yscF, which
encodes the major structural subunit of the needle, was classified
as strongly selected in vivo (relative fitness 0; see Table S4). lcrV,
yopB, and yopD, encoding the translocon apparatus, also had large
reductions in relative fitness (0, 0.55, and 0.69). Among the se-
creted effectors, insertions in the genes encoding a GTPase-
activating enzyme (yopE), a tyrosine phosphatase (yopH), and a
regulatory effector (yopK) suffered clearly significant reductions
in relative fitness (Fig. 7; see also Table S4). We did not detect a
reduction in fitness for insertions in the effector-encoding genes
yopM (encoding a possible inhibitor of inflammasome activa-
tion), ypkA (encoding a serine/threonine kinase), or yopT (encod-
ing a cysteine protease). Insertions in yopJ (encoding an acetyl-
transferase) showed weak but not significant positive selection.
These results are consistent with previous reports that some effec-
tors are crucial while others appear to contribute verymodestly or
not at all to virulence (48–53).
pMT1.No genes on pMT1 experienced significant selection in
vivo. pMT1 carries a gene encoding a phospholipase D, ymt
(Y1069), that was initially thought to contribute to virulence in
mice; however, the lack of apparent selection on ymt is in accor-
dance with more recent reports that ymt primarily promotes bac-
terial survival in the flea vector (54) rather than enhancing viru-
lence in mammals (55). pMT1 also carries a gene, caf1 (Y1100),
encoding the fraction 1 capsule protein,which produces abundant
pili loosely associatedwith the cell surface. As with ymt, we did not
detect significant selection of caf1 in vivo.
pPCP1. None of the five annotated ORFs on pPCP1 experi-
enced significant selection in vivo. pPCP1 encodes a single char-
acterized virulence factor, the plasminogen activator encoded by
pla, which plays a crucial role in progression to systemic infection
following subcutaneous or intradermal infection (41, 56) but is
less important in pulmonary infection (57) and has little effect
following intravenous infection (58). Failure of pla mutants to
show a fitness deficit in the Tn-seq data set is thus not surprising.
FIG 6 ptsG provides a competitive advantage in the presence of glucose. (A) A 104-CFU dose of wild-type KIM1001 and KIM1001ptsG (mixed 1:1) was
injected intravenously into BALB/C or C57BL/6 mice. The proportion of KIM1001ptsGmutants in the population of Y. pestis in the spleen was determined 2
and 42 h postinfection by plating on TB supplemented with 2.5 mM CaCl2, 1% glucose, and 50 g/ml tetrazolium red. (B) The attenuated strains JG102 and
JG102ptsG were mixed 1:1 in the rich medium TB, in TB supplemented with 5 mM glucose, and in the defined medium SNM (n 5 for each condition). The
proportion of JG102ptsG in each culture was measured before and after 42 h of log-phase growth.
FIG 7 Many genes on the type III secretion plasmid pCD1 undergo strong
selection during infection. Each gene on pCD1 was compared between two in
vitro data sets (filled pale blue squares) or between an in vitro data set and the
in vivo data set (gray circles). Genes experiencing significant selection in vivo
are represented by black circles. Genes harboring no sequenced insertions in
vivo in the central 90% of the ORF (relative fitness 0) are shown in the box
at the left of the plot. The effector proteins of the type III secretion system
undergo variable levels of selection (red, yopH; yellow, yopE; dark blue, yopK;
orange, ypkA; purple, yopM; pink, yopT; green, yopJ), while the ATPase (tan,
yscN) and structural components (tan, yscF) undergo strong selection.
Palace et al.
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DISCUSSION
We detected a substantial fraction of the genes previously impli-
cated in the virulence of Y. pestis (see Table S5 in the supplemental
material). Some of the virulence genes not detected have been
shown to be important via subcutaneous but not intravenous in-
fection (e.g., pla and yadBC), while others may well have this
property (ail, caf1, and psa; see Table S5). Alternatively, intercel-
lular complementationmaymask the requirement for caf1 and/or
psa, since both of these genes encode highly abundant secreted
proteins. Our results are also generally in agreement with the re-
cent study by Crimmins et al., which reports Tn-seq data for the
closely related species Y. pseudotuberculosis following intravenous
infection (25). As in our study, these investigators found crucial
roles in vivo for purine biosynthesis (purM, purH, purC, and
purD), aromatic amino acid biosynthesis (aroA and aroE), and
LPS modification (arnD) (25). The remaining differences in our
resultsmay reflect biological differences between these two organ-
isms, which differ in requirements for growth in vitro and cause
very different diseases, but also reflect the increased sensitivity and
resolution of our experiments, which employed a 100-fold-larger
library.
A comparison of the Tn-seq data set to the in vivo competition
data for a defined panel of Y. pestismutants recently published by
Pradel et al. (15) reveals several genes with reduced fitness in both
experiments. Interestingly, however, there remains considerable
disagreement between the candidates identified by Pradel et al.
and results of the Tn-seq approach described here. In particular,
Pradel et al. found that ptsGmutants are attenuated in a subcuta-
neous single-infection model, whereas we found that ptsG mu-
tants remained fully virulent. It is possible that the low dose used
by Pradel et al., which they report as 10 CFU, may explain this
discrepancy.
Many genes experiencing significant in vivo selection during
the Tn-seq experiment have roles in nutrient import or biosyn-
thesis. The widespread use of rich media containing nutritional
conditions not found in the host in both clinical and research
settings may partly explain why these genes are often overlooked
as therapeutic targets. As an illustration of this principle, the poor
fitness of brnQ mutants in vivo cannot be detected on the rich
medium TB but is readily apparent in media specifically designed
to mimic nutritional conditions in serum. As illustrated by the
strong immunity induced by infection with our brnQ mutant,
importers required for nutrition in vivomay also be useful for the
rational design of strains to be used as live vaccines.
Even inmedia recapitulating the in vivo environment, a growth
defect in vitro does not always translate to reduced virulence. The
behavior of brnQmutants versus that of ptsGmutantsmakes clear
the important distinction between fitness and virulence: the de-
tection of reduced relative fitness by Tn-seq does not necessarily
imply attenuation of the corresponding mutant. In vivo fitness
and virulence can be distinct properties, especially when the fit-
ness reduction is small.
With a few exceptions, Tn-seq studies reported to date present
the observed effect of mutants in a given gene either as a ratio of
the raw frequencies (e.g., see reference 22) or the log base 2 of this
ratio (e.g., see reference 21). As we have done here, van Opijnen
and Camilli (35) use the metric of relative fitness. We suggest the
adoption of this measure as a standard for the presentation of
Tn-seq results. The ratio of raw frequencies yields extreme values
that can bemisleading. Log base 2 of these ratios is proportional to
relative fitness, but the constant of proportionality will differ de-
pending on experimental details, and hence thismetricmay not be
directly comparable among studies. Relative fitness suffers from
neither of these complications and has several additional advan-
tages:most importantly, its readily interpreted biologicalmeaning
and its congruence with the formal definitions for the synergy or
independence of mutational effects. The latter is especially useful
in genetic interaction studies, in which libraries constructed in
specific mutant backgrounds are to be compared with libraries
constructed in the wild-type parent.
The wealth of available data on Yersinia pestis pathogenesis
enables the critical evaluation of the Tn-seqmethod in the context
of infection studies. For example, the intercellular complementa-
tion of the yersiniabactin siderophore system suggests that inter-
cellular complementationmay be a common phenomenon in Tn-
seq and relatedmethods. In support of this conclusion, Price et al.
observed strong intercellular complementation of the Y. pestis
T3SS in lung tissue when they applied an alternate technique for
screening transposon mutant libraries (TraSH) (59). The pattern
we observe in the yersiniabactin system—a cluster of genes de-
voted to synthesis of a secondary metabolite not under selection,
coupled to a transporter under strong selection—may be a signa-
ture for intercellular complementation by a highly diffusible small
molecule. In the context of pathogenesis, a lack of an observed
fitness deficit in Tn-seq studies cannot be interpreted as definitive
evidence that the gene in question would not be important, or
even essential, if the mutant were in pure culture.
The requirement for a large inoculum to provide good cover-
age of the genome is perhaps the most important limitation of the
Tn-seq method. One of the most important properties of Y. pestis
is its ability to produce systemic infection following intradermal
inoculation with a few bacteria; however, this problem cannot be
practically addressed by Tn-seq due to bottleneck effects that re-
duce library diversity. As the work by Pradel et al. illustrates, a
genomic-scale approach to identifying the genes required for in-
fection via a peripheral route would be practicable only with an
ordered array library orders of magnitude smaller than the ran-
dom library used here and even then would require a large num-
ber ofmice to limit inoculum size and overcomemouse-to-mouse
variation (15). Nonetheless, as we have shown here, even very
large inocula (in our case, more than 2 million LD50s) can yield a
wealth of data that accurately reflect the underlying biology estab-
lished over many years for Y. pestis. The in vivo application of
Tn-seq is clearly an approach of extraordinary power that should
greatly accelerate the understanding ofmany pathogens. Develop-
ment of adequate libraries may be a significant obstacle in many
species, but effort devoted to overcoming this obstacle is very
likely to be a worthwhile investment.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains used in this study and
details of strain construction are presented in Text S1 in the supplemental
material. Unless otherwise specified, E. coli strains were cultured in Luria
broth (LB) and Y. pestis strains in the rich medium TB, prepared to max-
imize plating efficiency as previously described (60). Additional experi-
ments were performed in the defined media PMH2 (42) or SNM (see
Text S1). All Y. pestis cultures were supplemented with 2.5 mM CaCl2 to
suppress type III secretion.Where appropriate,mediawere supplemented
with 100g/ml ampicillin, 25g/ml zeocin, or 25g/ml diaminopimelic
acid.
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Library construction andTn-seq.Experimental details of library gen-
eration, selection, preparation for Illumina sequencing, sequence read
processing, and statistical analysis are available in Text S1 in the supple-
mental material. Raw sequence reads are available in the NCBI Sequence
Read Archive (SRA) (http://www.ncbi.nlm.nih.gov/Traces/sra) under
BioProject PRJNA240677, accession numbers SRX483428 (reference in
vitro library), SRX483566 (replicate in vitro library), and SRX483575 (in
vivo library).
Animal infections. This study was conducted in conformity with the
Guide for the Care and Use of Laboratory Animals of the National Insti-
tutes of Health and with the review and approval of the University of
Massachusetts Medical School Institutional Animal Care and Use Com-
mittee (IACUC).
C57BL/6 and BALB/Cmice were infected as appropriate. All bacterial
cultures used for inoculationwere grown at 37°C onTB agar (TBmedium
with 1.5% agar) containing 2.5 mM CaCl2 overnight prior to infection.
Bacterial cells were diluted in infection-grade phosphate-buffered saline
(PBS) to the desired concentration. In every case, the number of viable
bacteria present in each dose was verified by dilution plating of the inoc-
ulum. Mice were monitored every 12 h for signs of illness, such as ruffled
fur, shallow breathing, limping, reluctance to move, and swollen lymph
nodes.
ptsG competition experiments. Mice were sacrificed 2 h or 42 h fol-
lowing coinfection with 3  103 CFU of a 1:1 mixture of KIM1001 and
KIM1001ptsG. Spleens were removed and homogenized in 0.5ml sterile
PBS. Dilutions were plated on TB agar containing 2.5 mM CaCl2, 1%
glucose, and 50 g/ml tetrazolium red. On this medium, the wild-type
strain KIM1001 forms white colonies, while colonies of KIM1001ptsG
are purple (61). In vitro competition experiments were performed bymix-
ing JG102 and JG102ptsG 1:1 and plating cultures onTB agar containing
2.5mMCaCl2, 1% glucose, and 50g/ml tetrazolium red after 0 h or 42 h
of continuous log-phase growth at 37°C. The fraction of JG102ptsG
colonies was determined by calculating the fraction of purple colonies on
these dilution plates.
Because the JG102 strain and the complemented strain
JG102ptsG(pZS*13luc::ptsG) both ferment glucose, both form white
colonies on TB agar supplemented with 1% glucose and 50 g/ml tetra-
zolium red. In vitro competition experiments with the complemented
strain were therefore performed against the control strain,
JG102xylB(pZS*13luc), cultured in the presence of 100 g/ml ampicil-
lin. Dilutions were plated on TB agar supplemented with 2.5 mM CaCl2,
1% xylose, and 30 g/ml neutral red after 0 h or 42 h of continuous
log-phase growth at 37°C. On these plates, the complemented strain,
JG102ptsG(pZS*13luc::ptsG), forms white colonies, and the control
strain, JG102xylB(pZS*13luc), forms red colonies. The fraction of
JG102ptsG(pZS*13luc::ptsG) colonies was determined by calculating
the fraction of red colonies on these dilution plates.
The change in the growth rate was determined by plotting the natural
log of the ratio of the ptsG mutant to the wild-type strain over time and
calculating the slope by linear regression. Absolute change in growth rate
was applied to the measured growth rate for the wild-type strain to deter-
mine mutant growth rates.
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